Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Device Daily Bulletin
> Boston Scientific’s New CEO Begins Tenure
FDAnews Device Daily Bulletin
Nov. 2, 2012
| Vol. 9 No. 216
Boston Scientific’s New CEO Begins Tenure
Michael Mahoney is officially taking charge at Boston Scientific, becoming its CEO after a one-year stint as president at the device maker.
Businessweek
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
‘Significant Decision’ Clarified in CDRH Appeals Guidances
Man Makes Medical History
Focus: Wireless Power for Tiny Medical Devices
University of Limerick Invents a New Metal for Medical Devices